v3.26.1
Schedule of Summary of Consolidated Net Loss (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Segment Reporting [Line Items]        
Revenues $ 778 $ 747 $ 43
Cost of sales 635 609
Research and development     848 6,655
Total operating expenses 1,024 4,214 9,174 12,047
Operating loss (246) (4,214) (8,427) (12,004)
Total other income (expense), net 79 8 5,436 10
Loss before taxes (167) (4,206) (2,991) (11,994)
Income tax benefit / (charge) (30) (7) 782
Net loss $ (197) $ (81) (2,998) (11,212)
Single Reportable Segment [Member]        
Segment Reporting [Line Items]        
Revenues     747 43
Cost of sales     609
Research and development     848 6,655
General and administrative     7,717 5,392
Total operating expenses     9,174 12,047
Operating loss     (8,427) (12,004)
Total other income (expense), net     5,436 10
Loss before taxes     (2,991) (11,994)
Income tax benefit / (charge)     (7) 782
Net loss     $ (2,998) $ (11,212)